Afshan A. Nanji, M.D.
Cornea and External Diseases Specialist Physician · Portland, OR
Afshan A. Nanji, M.D. is a cornea and external diseases specialist physician with a practice address in Portland, Oregon, and NPI 1134381718, issued on Jun 25, 2008. Check the license (Oregon MD167533, as entered in NPPES) on the Oregon Medical Board; the Medicare figures below come from public CMS files.
- Name
- Afshan A. Nanji
- Credential
- M.D.
- Primary taxonomy
- Cornea and External Diseases Specialist Physician 207WX0120X
- License number
- MD167533 OR
Self-reported in NPPES; status is on the state search - Practice location
- 3375 SW Terwilliger Blvd, Portland, OR 97239
- Phone
- (503) 494-3000
- Enumerated
- Jun 25, 2008
- Record last updated
- Apr 6, 2018 (not updated in 8 years: call before relying on the address or phone)
- Fax
- (503) 494-3929
- Medicaid ID
- 500673738 OR
- Medicare enrollment
- Enrolled (PECOS I20140722002544); accepts Medicare assignment
- Medical or professional school
- Johns Hopkins University School Of Medicine, 2008
- Entity
- Type 1 · individual
Also registered at 3375 SW Terwilliger Blvd
A shared address usually means a shared clinic or building; it does not show who employs whom.
- Talal Alabduljalil, MDOphthalmology Physician1689044273
- Daniel Albert, MDOphthalmology Physician1801862388
- Kavita Bhavsar, MDRetina Specialist (Ophthalmology) Physician1720216765
- Kristin Biggee, M.D.Ophthalmology Physician1376719591
- Amanda Burr, MS, CGCGenetic Counselor (M.S.)1770013252
- Mauricio Cabezas, M.D.Ophthalmology Physician1295970424
Verify Afshan A. Nanji in five checks
- 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
- 2LicenseActive license and public ordersOregon Medical Board
Search for license MD167533Check the board - 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
- 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
- 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
61% fewer Medicare Part D claims than the average cornea and external diseases specialist physician in 2024
492 Medicare Part D claims for 140 beneficiaries, against an average of 1,263 among the 330 providers of this specialty who prescribed in Part D. Brand-name drugs were 44% of claims.
Most prescribed
- Prednisolone Acetate123 claims
- Fluorometholone95 claims
- Ofloxacin68 claims
- Ketorolac Tromethamine28 claims
- Erythromycin24 claims
- Valacyclovir24 claims
Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.
The MIPS final score for 2023 (Medicare payment program): 97.8 of 100
The Merit-based Incentive Payment System score is reported for this clinician. Four categories are weighted into the final score; the average among 454,083 clinicians with a measured score was 83.5.
Source: CMS Quality Payment Program, MIPS performance year 2023; category weights for 2023 (qpp.cms.gov).
Industry payments in 2024: $127.65
2 payments; by number, the most common kind was food and beverage; the largest payer was Apellis Pharmaceuticals, Inc. The 284 providers of this specialty with any payment received $3,109.37 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.
Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.
Bills Medicare through one group practice
- University Professional ServicesBeaverton, OR
Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through) (data.cms.gov).
Cornea and External Diseases Specialist Physician providers in Oregon
There are 10 cornea and external diseases specialist physician records in Oregon.
Other cornea and external diseases specialist physician records in Oregon
- Winston Chamberlain, MD, PHDPortland, OR1710108162
- John Clements, MDPortland, OR1700907516
- David Demill, M.D.Portland, OR1366783631
- Ashlin JoyePortland, OR1629531116
- Matthew Oliva, MDMedford, OR1750450573
- Roma Pegany, MDPortland, OR1194215319
- Michael Straiko, M.D.Portland, OR1013127075
- Mark Terry, MDPortland, OR1760498737
- John Welling, MDMedford, OR1306159173
Common questions
What is Afshan A. Nanji, M.D.'s NPI number?
Afshan A. Nanji, M.D.'s National Provider Identifier (NPI) is 1134381718, issued on Jun 25, 2008. An NPI identifies a provider in billing; it is not a license.
Where is Afshan A. Nanji, M.D. located?
The NPPES record lists a practice address at 3375 SW Terwilliger Blvd, Portland, OR, 97239. Phone: (503) 494-3000. Providers update this record themselves, so call before visiting.
How can I verify Afshan A. Nanji, M.D.'s license?
NPPES lists Oregon license number MD167533, as entered by the provider. Search the Oregon Medical Board at https://www.oregon.gov/OMB/Pages/default.aspx. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.
How much does Afshan A. Nanji, M.D. prescribe under Medicare Part D?
In 2024, Afshan A. Nanji, M.D. had 492 Medicare Part D claims for 140 beneficiaries; the average among cornea and external diseases specialist physician prescribers was 1,263. Part D covers Medicare prescriptions only.
What is Afshan A. Nanji, M.D.'s MIPS final score?
The 2023 MIPS final score is 97.8 of 100. The average among 454,083 clinicians with a measured score was 83.5.
Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.
Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.